Recently Viewed

News Announcement

Aurobindo Pharma: Curateq Biologics Secures Health Canada NOC For Bevqolva™ Bevacizumab Biosimilar

01-May-2026 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

This is to inform you that Curateq Biologics Private Limited a wholly owned subsidiary of the Company secures Health Canada NOC for Bevqolva Bevacizumab Biosimilar.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.